title: Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated?: The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum".
authors: From Division of Cardiology, Department of Medicine, Hennepin County Medical Center and the University of Minnesota, Minneapolis (R.W.A., G.A.S, C.A.H.); and Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN (C.A.H.).
authors: Richard W
authors: RW
authors: Asinger
authors: From Division of Cardiology, Department of Medicine, Hennepin County Medical Center and the University of Minnesota, Minneapolis (R.W.A., G.A.S, C.A.H.); and Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN (C.A.H.).
authors: Gautam R
authors: GR
authors: Shroff
authors: From Division of Cardiology, Department of Medicine, Hennepin County Medical Center and the University of Minnesota, Minneapolis (R.W.A., G.A.S, C.A.H.); and Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN (C.A.H.).
authors: Charles A
authors: CA
authors: Herzog
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D003657:Decision Making; D005260:Female; D006801:Humans; D008297:Male; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke
chemical_list: D000925:Anticoagulants